Epigenetic regulation affects N-myc downstream-regulated gene 1 expression indirectly in pancreatic cancer cells.
Epigenetic regulation affects N-myc downstream-regulated gene 1 expression indirectly in pancreatic cancer cells.
复制标题
DOI:
10.1097/mpa.0b013e3181c8b476
复制
发表时间:
2010-07
期刊:
影响因子:
2.9
通讯作者:
Eibl G
中科院分区:
文献类型:
--
作者:
Angst E;Dawson DW;Nguyen A;Park J;Go VL;Reber HA;Hines OJ;Eibl G
N-myc downstream regulated gene-1 (NDRG1), important in tumor growth and metastasis, has recently gained interest as a potential therapeutic target. Loss of NDRG1 expression is generally associated with poor clinical outcome in pancreatic cancer (PaCa) patients. As the NDRG1 gene possesses a large promoter CpG island, we sought to determine whether its repression is epigenetically mediated in PaCa cells. PaCa cells were treated with the DNA methyltransferase inhibitor 5-Aza-2’-deoxycytidine (AZA) and the histone deacetylase inhibitor Trichostatin A (TSA). Promoter methylation was assessed by genomic bisulfite sequencing, and by combined bisulfite restriction analyses. Treatment with AZA and TSA enhanced NDRG1 protein expression, implicating epigenetic regulation of NDRG1. However, there was no significant DNA methylation of the NDRG1 promoter CpG island, as determined by genomic bisulfite sequencing of HPAF-II cells. We further confirmed the lack of promoter methylation in six PaCa cell lines by combined bisulfite restriction analyses. These findings indicate that NDRG1 gene reactivation in PaCa cell lines by pharmacologic reversal of DNA methylation and histone deacetylation occurs via an indirect mechanism. This may occur via the altered expression of genes involved in the regulation of NDRG1 transcription or NDRG1 protein stability in PaCa cells.